Brandon Medical has more than doubled production at its Leeds factory to manufacture vital equipment for the UK’s fightback against coronavirus.
The company is responding to “massive demand” from NHS organisations for its world-leading medical technology to help support the treatment of people suffering from the disease.
Brandon Medical is a UK designer and manufacturer of world-leading integrated, smart technology for primary and secondary care institutions.
For more than 70 years, the company has provided healthcare professionals with reliable, high-quality and affordable medical equipment packages for operating theatres and critical care.
Brandon Medical is currently manufacturing medical lighting and supplying failsafe portable power supplies and medical gas systems for intensive treatment units at NHS and worldwide hospitals and trusts.
Graeme Hall, executive chairman, said: “Anything the NHS asks that we can do, we do it.
“We are now producing twice as many products because of the extraordinary demand coming from our national health service.
“Orders for the first five months of the financial year have already exceeded our entire sales for 2019.
“Our factory employees are proud to step up because they know our efforts will play a vital role in helping the NHS to fight coronavirus.”
Earlier this week, Mr Hall sent a message of solidarity to Italian competitor RIMSA P. Longoni SRL, which is based in the stricken Lombardy region and is carrying on production to support the Italian effort.
Carlo Longoni, chief executive of RIMSA, said: “It’s so beautiful to receive your solidarity and to know that even competitors, first we are friends.
“The goal of our job isn’t to make profit, but to put a small drop of water in the big ocean that is our world and make proudly our part.”
Mr Hall said: “This is a sentiment shared by the entire Brandon Medical team.
“We are putting every effort into production at our Leeds headquarters and going into hospitals to install all the required equipment at the frontline of defence against COVID-19.”